1. The views of parents and children and young people are important in informing trial design and conduct.|
2. Although families may not deem one treatment as unsuitable overall, trialists need to establish whether all treatments are suitable for all patients with JIA. If this is not possible, amendments to the eligibility criteria or fewer treatments will be needed.
3. Further qualitative work should explore clinicians’ views on a future corticosteroid induction regimen trial in JIA, to establish clinical equipoise and support for the trial.
4. Trialists should consider methods of making a future trial more accessible to parents and children and young people, such as combining trial follow-up assessments with clinic appointments.